Project/Area Number |
15K09875
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Psychiatric science
|
Research Institution | Keio University |
Principal Investigator |
|
Co-Investigator(Renkei-kenkyūsha) |
PARK Sunre 慶應義塾大学, 看護医療学部, 講師 (90338195)
SADO Mitsuhiro 慶應義塾大学, 医学部, 講師 (10317266)
JINNO Hiromitsu 帝京大学, 医学部, 教授 (20216261)
NAKAGAWA Atsuo 慶應義塾大学, 医学部, 特任講師 (30338149)
|
Research Collaborator |
TAMURA Noriko 慶應義塾大学, 医学部, 研究員
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 心理療法 / 認知行動療法 / マインドフルネス / がん / うつ / 不安 / 倦怠感 / QOL / QOL / 乳がん / 精神療法 / サイコオンコロジー / マインドフルネス認知療法 |
Outline of Final Research Achievements |
This study aimed to examine effectiveness of mindfulness-based cognitive therapy (MBCT) for psychological and physical symptoms of breast cancer patients. A total of 74 patients with stage I-III breast cancer were randomized to eight-session MBCT or wait-list control. After eight weeks, patients in the MBCT group had significantly lower level of depression and anxiety (Hospital Anxiety and Depression Scale: HADS) lower fear of cancer recurrence (Concerns about Recurrence Scare: CARS), better spiritual well-being (Functional Assessment of Chronic Illness Therapy Spiritual Well-being Scale: FACIT-Sp), lower fatigue (Brief Fatigue Inventory: BFI), better mindfulness attitude (Five Facet Mindfulness Questionnaire: FFMQ), and better QOL (Functional Assessment of Cancer Therapy - General: FACT-G) (all p < 0.01). This significant difference sustained at four weeks after completion of the program. This is the first study in Japan that demonstrated effectiveness of MBCT for cancer patients.
|